Form 8-K - Current report:
SEC Accession No. 0001193125-21-034288
Filing Date
2021-02-09
Accepted
2021-02-09 16:00:30
Documents
12
Period of Report
2021-02-07
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d102565d8k.htm   iXBRL 8-K 24473
  Complete submission text file 0001193125-21-034288.txt   150307

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA acet-20210207.xsd EX-101.SCH 3073
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE acet-20210207_lab.xml EX-101.LAB 18888
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acet-20210207_pre.xml EX-101.PRE 11862
5 EXTRACTED XBRL INSTANCE DOCUMENT d102565d8k_htm.xml XML 3468
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 21606301
SIC: 2834 Pharmaceutical Preparations